Table 3.
Comparison of renal outcomea
| Variables | Grade 1 obesity, n = 20 | Grade 2 or higher obesity, n = 20 | P value |
|---|---|---|---|
| Duration of follow-up (yr) | 6.2 ± 3.0 | 6.2 ± 2.8 | 0.944 |
| Use of ACE-I/ARB (%) | 90 | 85 | 0.633 |
| Use of corticosteroids or immunosuppressants (%) | 0 | 0 | – |
| ΔeGFR (%/yr) | 7.4 ± 9.2 | 5.8 ± 7.1 | 0.450 |
| Patients with a 30% decrease in eGFR at the last observation (%) | 50 | 40 | 0.525 |
| Patients with a 50% decrease in eGFR at the last observation or those reached ESRD (%) | 25 | 15 | 0.212 |
ACE-I, angiotensin-converting enzyme inhibitor; ARB; angiotensin receptor blocker; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease.
a
Patients with >2-yr follow-up were included in the analyses.